Pravastatin Zentiva 20

Pravastatin Zentiva 20 is a medicine authorised by Swissmedic under authorisation number 57535. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 August 2005 and the authorisation is valid without a time limit. ATC code C10AA03 places the medicine in the group Lipid modifying agents.

  • Dispensing category B
  • Authorisation number 57535
  • ATC C10AA03
  • Synthetic medicines
Authorisation data
Authorisation number57535
NamePravastatin Zentiva 20
Full namePravastatin Zentiva 20, Tabletten
Authorisation holderHelvepharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC10AA03
First authorisation29 August 2005
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Pravastatin Zentiva 20, TablettenB29 August 2005
3Pravastatin Zentiva 40, TablettenB29 August 2005

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
530Tablette(n)C10AA0307.12.0.B
7100Tablette(n)C10AA0307.12.0.B
930Tablette(n)C10AA0307.12.0.B
11100Tablette(n)C10AA0307.12.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Pravastatin Zentiva 20 authorised in Switzerland?

Yes. Pravastatin Zentiva 20 is authorised by Swissmedic under authorisation number 57535, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Pravastatin Zentiva 20 have?

Pravastatin Zentiva 20 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Pravastatin Zentiva 20?

The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com